Typing TREX1 gene in patients with systemic lupus erythematosus

Reumatismo

Volumn 67, Issue 1, 2015, Pages 1-14

  Fredi, Micaela ^a,b,c   Bianchi, M ^d   Andreoli, L ^a,b   Greco, G ^d   Olivieri, I ^d   Orcesi, S ^d   Fazzi, E ^b   Cereda, C ^d   Tincani, A ^a,b  

^a SPEDALI CIVILI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Neuropsychiatric systemic lupus erythematosus; Novel variation; TREX1

Indexed keywords

DNA EXONUCLEASE; EXONUCLEASE; NUCLEIC ACID; SINGLE STRANDED DNA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; EXODEOXYRIBONUCLEASE; PHOSPHOPROTEIN; THREE PRIME REPAIR EXONUCLEASE 1;

ADULT; ALLELE; ARTICLE; CHROMOSOME 3; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME SPECIFICITY; EUROPEAN; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MISSENSE MUTATION; NEUROLOGIC DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TREX1 GENE; BLOOD; GENETICS; GENOTYPING TECHNIQUE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ALLELES; BIOMARKERS; EXODEOXYRIBONUCLEASES; GENOTYPING TECHNIQUES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUTATION, MISSENSE; PHENOTYPE; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84936770481     PISSN: 00487449     EISSN: 22402683     Source Type: Journal    
DOI: 10.4081/reumatismo.2015.782     Document Type: Article

References (25)

1. Hoss M, Robins P, Naven TJ, Pappin DJ, Sgouros J, Lindahl T. A human DNA editing enzyme homologous to the Escherichia Coli DnaQ/MutD protein. EMBO J. 1999; 18: 3868-75.
2. Chowdhury D, Beresford PJ, Zhu P, Zhang D, Sug J, Demple B, et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme a-mediated cell death. Mol Cell. 2006; 23: 133-42.
3. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008; 134: 587-98.
4. Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, et al Gene-targeted mice lacking the Trex1 (DNase III) 3'→ 5' DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol. 2004; 24: 6719-27.
5. Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, Ali M, et al Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet. 2006; 38: 917-20.
6. Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, et al Clinical and molecular phenotype of Aicardi-Goutières syndrome. Am J Hum Genet. 2007; 81: 713-25.
7. Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet. 2007; 80: 811-5.
8. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, et al Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet. 2007; 39: 1065-7.
9. Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 2011; 12: 270-9.
10. Barizzone N, Monti S, Mellone S, Godi M, Marchini M, Scorza R, et al. Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. Biomed Res Int. 2013; 2013: 471703.
11. Aicardi J, Goutières F. A progressive familial encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol. 1984; 15:49-54.
12. Rice GI, del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet. 2014; 46: 503-9.
13. Ramantani G, Kohlhase J, Hertzberg C, Innes AM, Engel K, Hunger S, et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis Rheum. 2010; 62: 1469-77.
14. De Laet C, Goyens P, Christophe C, Ferster A, Mascart F, Dan B. Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi-Goutieres syndrome. Neuropediatrics 2005; 36: 399-402.
15. de Vries B, Steup-Beekman GM, Haan J, Bollen EL, Luyendijk J, Frants RR, et al. TREX1 gene variant in neuropsychiatric systemic lupus erythematosus. Ann Rheum Dis. 2010; 69: 1886-7.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725.
17. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortinet PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64: 2677-86.
18. Rost B, Yachdav G, Liu J. The predict protein server. Nucleic Acids Res. 2004; 32: W321-6.
19. Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010;11: 548.
20. Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011; 1238: 91-8.
21. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006; 25: 383-92.
22. Orebaugh CD, Fye JM, Harvey S, Hollis T, Perrino FW. The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity. J Biol Chem. 2011; 286: 40246-54.
23. Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl). 2007; 85: 531-7.
24. Günther C, Meurer M, Stein A, Viehweg A, Lee-Kirsch MA. Familial chilblain lupus-a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1. Dermatology. 2009; 219: 162-6.
25. Haaxma CA, Crow YJ, van Steensel MA, Lammens MM, Rice GI, Verbeek MM, et al. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutières syndrome. Am J Med Genet. 2010; 152A: 2612-7.